Authors:
Qin, KF
Yang, DS
Yang, Y
Chishti, MA
Meng, LJ
Kretzschmar, HA
Yip, CM
Fraser, PE
Westaway, D
Citation: Kf. Qin et al., Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP - Effect of protein age and deamidation, J BIOL CHEM, 275(25), 2000, pp. 19121-19131
Authors:
Herms, J
Neidt, I
Luscher, B
Sommer, A
Schurmann, P
Schroder, T
Bergmann, M
Wilken, B
Probst-Cousin, S
Hernaiz-Driever, P
Behnke, J
Hanefeld, F
Pietsch, T
Kretzschmar, HA
Citation: J. Herms et al., c-myc expression in medulloblastoma and its prognostic value, INT J CANC, 89(5), 2000, pp. 395-402
Authors:
Durig, J
Giese, A
Schulz-Schaeffer, W
Rosenthal, C
Schmucker, U
Bieschke, J
Duhrsen, U
Kretzschmar, HA
Citation: J. Durig et al., Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes, BR J HAEM, 108(3), 2000, pp. 488-496
Authors:
Schulz-Schaeffer, WJ
Tschoke, S
Kranefuss, N
Drose, W
Hause-Reitner, D
Giese, A
Groschup, MH
Kretzschmar, HA
Citation: Wj. Schulz-schaeffer et al., The paraffin-embedded tissue blot detects PrPSC early in the incubation time in prion diseases, AM J PATH, 156(1), 2000, pp. 51-56
Authors:
Neumann, M
Adler, S
Schluter, O
Kremmer, E
Benecke, R
Kretzschmar, HA
Citation: M. Neumann et al., alpha-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies, ACT NEUROP, 100(5), 2000, pp. 568-574
Authors:
Skworc, KH
Windl, O
Schulz-Schaeffer, WJ
Giese, A
Bergk, J
Nagele, A
Vieregge, P
Zerr, I
Poser, S
Kretzschmar, HA
Citation: Kh. Skworc et al., Familial Creutzfeldt-Jakob disease with a novel 120-bp insertion in the prion protein gene, ANN NEUROL, 46(5), 1999, pp. 693-700
Authors:
Harder, A
Jendroska, K
Kreuz, F
Wirth, T
Schafranka, C
Karnatz, N
Theallier-Janko, A
Kreier, J
Lohan, K
Emmerich, D
Cervos-Navarro, J
Windl, O
Kretzschmar, HA
Nurnberg, P
Witkowski, R
Citation: A. Harder et al., Novel twelve-generation kindred of fatal familial insomnia from Germany representing the entire spectrum of disease expression, AM J MED G, 87(4), 1999, pp. 311-316
Authors:
Samman, I
Schulz-Schaeffer, WJ
Wohrle, JC
Sommer, A
Kretzschmar, HA
Hennerici, M
Citation: I. Samman et al., Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity atcodon 129 and prion protein type 2, J NE NE PSY, 67(5), 1999, pp. 678-681
Authors:
Wiltfang, J
Otto, M
Baxter, HC
Bodemer, M
Steinacker, P
Bahn, E
Zerr, I
Komhuber, J
Kretzschmar, HA
Poser, S
Ruther, E
Aitken, A
Citation: J. Wiltfang et al., Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease, J NEUROCHEM, 73(6), 1999, pp. 2485-2490
Authors:
Windl, O
Lorenz, H
Behrens, C
Romer, A
Kretzschmar, HA
Citation: O. Windl et al., Construction and characterization of murine neuroblastoma cell clones allowing inducible and high expression of the prion protein, J GEN VIROL, 80, 1999, pp. 15-21
Citation: A. Burkle et al., Poly(ADP-ribose) immunostaining to detect apoptosis induced by a neurotoxic fragment of prion protein, HISTOCHEM J, 31(11), 1999, pp. 711-716